P25774 (CATS_HUMAN) Homo sapiens (Human)

Cathepsin S UniProtKBInterProSTRINGInteractive Modelling

331 aa; Sequence (Fasta) ; (Isoform 2)

Available Structures

62 Experimental Structures

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
Structure of Cathepsin S in complex with Compound 20bhomo-2-mer113-331
100EDO;FLC;SO4;Q1N;
Structure of Cathepsin S in complex with Compound 14homo-2-mer113-331
100FLC;Q1E;SO4;
Structure of Cathepsin S in complex with Compound 1homo-2-mer114-331
100SO4; 32×EDO;DMS;Q1K;FLC;
Structure of Cathepsin S in complex with Compound 2homo-2-mer114-331
100ACT;Q1H;SIN;MLA;
Structure of Cathepsin S in complex with Compound 3homo-2-mer114-331
100Q1Q;
THE CRYSTAL STRUCTURE OF A CYS25ALA MUTANT OF HUMAN PROCATHEPSIN Smonomer18-331
99.67
Cathepsin S in complex with non covalent arylaminoethyl amide.monomer112-331
100SO4;
Cathepsin S in complex with non-covalent 2-(Benzoxazol-2-ylamino)-acetamidemonomer112-331
100GNF;
Cathepsin S in complex with NNPI-C10 inhibitormonomer113-331
100EDO;PGE;NO3;GOL;PEG;
Cathepsin S Y132D mutant in complex with NNPI-C10 inhibitormonomer113-331
99.54CL;GOL;EDO;CD;ACT;PEG;
Crystal structure of human cathepsin S produced in insect cells in complex with ketoamide 13bmonomer114-331
100KH0;EDO;DMS;
Crystal Structure of Cathepsin S in complex with a Nonpeptidic Inhibitor.monomer114-331
100H7J;P15;
Crystal Structure of Human Cathepsin S Bound to a Non-covalent Inhibitor.monomer114-331
1002FZ;
Human Cathepsin S with Inhibitor CRA-26871monomer114-331
100C71;
Cathepsin S with nitrile inhibitormonomer114-331
100CRJ;
Crystal structure of human Cathepsin-S with bound ligandmonomer114-331
99.54BFV;
Crystal structure of human Cathepsin-S with bound ligandmonomer114-331
99.54N2D;
Crystal Structure of Human Cathepsin S Bound to a Non-covalent Inhibitormonomer114-331
100SO4;2FC;
Crystal structure of human Cathepsin-S with bound ligandmonomer114-331
99.54BGY;
Crystal structure of human Cathepsin-S with bound ligandmonomer114-331
99.54BQS;EOH;
Crystal structure of human Cathepsin-S with bound ligandmonomer114-331
99.54BQJ;
Crystal structure of human Cathepsin-S with bound ligandmonomer114-331
99.54BHJ;SO4;
Human Cathepsin S with Inhibitor CRA-27566monomer114-331
100CRL;
Crystal structure of human Cathepsin-S with bound ligandmonomer114-331
99.54B9Y;
Crystal structure of human Cathepsin-S with bound ligandmonomer114-331
99.54BC7;
Crystal structure of human Cathepsin-S with bound ligandmonomer114-331
99.54BG7;
Crystal structure of human Cathepsin-S with bound ligandmonomer114-331
99.54BJY;SO4;
Crystal structure of human Cathepsin-S with bound ligandmonomer114-331
99.54B9S;
Crystal structure of human Cathepsin-S with bound ligandmonomer114-331
99.54B8V;
Crystal structure of human Cathepsin-S with bound ligandmonomer114-331
99.54BCJ;
Crystal structure of human Cathepsin-S with bound ligandmonomer114-331
99.54SO4;GOL;BJV;
Crystal structure of human Cathepsin-S with bound ligandmonomer114-331
99.54BHV;
Crystal structure of human Cathepsin-S with bound ligandmonomer114-331
99.54SO4;BJS;
Crystal structure of human Cathepsin-S with bound ligandmonomer114-331
99.54N2A;
Crystal structure of human Cathepsin-S with bound ligandmonomer114-331
99.54BGJ;SO4;
Crystal structure of human Cathepsin-S with bound ligandmonomer114-331
99.54BAJ;
Crystal structure of human Cathepsin-S with bound ligandmonomer114-331
99.54BJD;
Cathepsin S in complex with a covalent inhibitor with an aldehyde warheadmonomer115-331
100O64;DMS;
The structure of cathepsin S with a novel 2-arylphenoxyacetaldehyde inhibitor derived by the Substr…monomer115-331
100SO4;TF5;PEU;
4-(3-Trifluoromethylphenyl)-pyrimidine-2-carbonitrile as cathepsin S inhibitors: N3, not N1 is crit…monomer115-331
100PEG;DMS;935;93N;
Human Cathepsin S with Inhibitor CRA-29728monomer115-331
100C28;
Crystal Structure of Cathepsin S in complex with a Zinc mediated non-covalent arylaminoethyl amidemonomer115-331
100ZN;CL;GNQ;
Crystal structures of Cathepsin S inhibitor complexesmonomer115-331
99.54C4P;
Human Cathepsin S with CRA-27934, a Nitrile Inhibitormonomer115-331
100CRV;
Crystal Structure of Cathepsin S in complex with a Nonpeptidic Inhibitor (Hexagonal spacegroup)monomer115-331
100SO4;H7J;
6-Phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile as cathepsin S inhibitorsmonomer115-331
100EF3;DMS;
Dipeptide Nitrile Inhibitor Bound to Cathepsin S.monomer115-331
100BLN;
Cathepsin S complexed with Compound 15monomer115-331
100Y11;
Crystal structures of Cathepsin S inhibitor complexesmonomer115-331
99.54C1P;
Human Cathepsin S with inhibitor CRA-16981monomer115-331
100MO9;
Cathepsin S complexed with Compound 26monomer115-331
100Y14;
Cathepsin S complexed with Compound 8monomer115-331
100Y15;
Crystal structure of human Cathepsin-S with bound ligandmonomer115-331
99.54BJD;SO4;GOL;
Pyrazole-based Cathepsin S Inhibitors with Arylalkynes as P1 Binding Elementsmonomer115-331
99.54599;
Crystal Structure of Cys25Ser mutant of human cathepsin Smonomer115-331
99.08
Mutant Human Cathepsin S with irreversible inhibitor CRA-14013monomer115-331
98.16BCQ;
Crystal structure of human Cathepsin-S with bound ligandmonomer115-331
99.54BQP;
Human cathepsin S mutant with vinyl sulfone inhibitor CRA-14009monomer115-331
99.08MQQ;
Crystal structure of human Cathepsin-S with bound ligandmonomer115-331
99.54SO4;BJJ;
Crystal structure of human Cathepsin-S with bound ligandmonomer115-331
99.54B8J;
Crystal structure of human Cathepsin-S with bound ligandmonomer115-331
99.54B8Y;
Crystal structure of human Cathepsin-S with bound ligandmonomer115-331
99.54B8S;

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
2c0y.1.Amonomer0.9118-331
99.68

1 SWISS-MODEL model built on isoform sequence

IsoformTemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 22c0y.1.Amonomer0.8620-281
95.80